AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,280,000 | +37.3% | 1,093,639 | +11.8% | 0.01% | +22.2% |
| Q2 2020 | $7,485,000 | +23.3% | 978,346 | -0.4% | 0.01% | 0.0% |
| Q1 2020 | $6,072,000 | -49.6% | 982,646 | -0.8% | 0.01% | -35.7% |
| Q4 2019 | $12,055,000 | +4.8% | 990,553 | -0.6% | 0.01% | 0.0% |
| Q3 2019 | $11,504,000 | +12.7% | 996,053 | -2.5% | 0.01% | +7.7% |
| Q2 2019 | $10,210,000 | -23.6% | 1,022,054 | -1.5% | 0.01% | -23.5% |
| Q1 2019 | $13,366,000 | -15.0% | 1,037,759 | +0.3% | 0.02% | -22.7% |
| Q4 2018 | $15,719,000 | -25.1% | 1,034,793 | -1.3% | 0.02% | -12.0% |
| Q3 2018 | $20,973,000 | +6.3% | 1,048,649 | +3.7% | 0.02% | -3.8% |
| Q2 2018 | $19,725,000 | +9.5% | 1,011,527 | +13.1% | 0.03% | +4.0% |
| Q1 2018 | $18,019,000 | +40.5% | 894,221 | -7.6% | 0.02% | +38.9% |
| Q4 2017 | $12,822,000 | -41.5% | 967,715 | -18.5% | 0.02% | -47.1% |
| Q3 2017 | $21,904,000 | +25.5% | 1,187,183 | +25.2% | 0.03% | +17.2% |
| Q2 2017 | $17,452,000 | -11.7% | 948,468 | +8.2% | 0.03% | -17.1% |
| Q1 2017 | $19,761,000 | -46.6% | 876,314 | -17.6% | 0.04% | -44.4% |
| Q4 2016 | $36,994,000 | +22.2% | 1,063,044 | -14.0% | 0.06% | +18.9% |
| Q3 2016 | $30,282,000 | -5.2% | 1,235,495 | -7.5% | 0.05% | -10.2% |
| Q2 2016 | $31,937,000 | -30.6% | 1,335,176 | -32.1% | 0.06% | -28.9% |
| Q1 2016 | $45,992,000 | -12.1% | 1,965,460 | +13.4% | 0.08% | +6.4% |
| Q4 2015 | $52,314,000 | +37.4% | 1,732,809 | +80.8% | 0.08% | +39.3% |
| Q3 2015 | $38,068,000 | -44.7% | 958,167 | -3.9% | 0.06% | -45.6% |
| Q2 2015 | $68,888,000 | +51.9% | 997,503 | +20.2% | 0.10% | +49.3% |
| Q1 2015 | $45,356,000 | +86.1% | 829,790 | +45.1% | 0.07% | +122.6% |
| Q4 2014 | $24,366,000 | +267.9% | 571,717 | +175.4% | 0.03% | +244.4% |
| Q3 2014 | $6,623,000 | +47.4% | 207,558 | -4.3% | 0.01% | +50.0% |
| Q2 2014 | $4,492,000 | -28.7% | 216,792 | -33.4% | 0.01% | -33.3% |
| Q1 2014 | $6,299,000 | +287.2% | 325,532 | +385.6% | 0.01% | +350.0% |
| Q4 2013 | $1,627,000 | -18.9% | 67,037 | -28.2% | 0.00% | -33.3% |
| Q3 2013 | $2,005,000 | +37.9% | 93,341 | +42.8% | 0.00% | 0.0% |
| Q2 2013 | $1,454,000 | – | 65,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |